US Patent Issued to GBG FORSCHUNGS on Aug. 11 for "Method for predicting the response to CDK4/6 inhibitor therapy in cancer patients" (German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,885, issued on Aug. 11, was assigned to GBG FORSCHUNGS GMBH (Neu-Isenburg, Germany).

"Method for predicting the response to CDK4/6 inhibitor therapy in cancer patients" was invented by Sibylle Loibl (Neu-Isenburg, Germany), Karsten Weber (Dreieich, Germany) and Baerbel Felder (Grasellenbach, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for predicting a response or resistance to and/or a benefit from treatment with an inhibitor of cyclin-dependent kinases 4 (CDK4/6 inhibitor) in a subject suffering from a neoplastic disease, particularly breast cancer, comprising the step of: determining in a sample...